Brief: N4 Pharma Says Transduction Efficacy Rose 2.5-Fold When Viral Vector Complexed With Nuvec Vs AAV8 Vector Used On Standalone Basis

Thalia Therapeutics

08/01/2024 07:12

Jan 8 (Reuters) - N4 Pharma PLC  N4P.L :
    * N4 PHARMA PLC - WHEN VIRAL VECTOR WAS COMPLEXED WITH
NUVEC,
TRANSDUCTION EFFICACY ROSE 2.5-FOLD VERSUS AAV8 VECTOR WHEN USED
ON A STANDALONE BASIS

Source text for Eikon:  ID:nRSH8399Ya 
Further company coverage:  N4P.L 

 ((Reuters.Briefs@thomsonreuters.com;))